NVO logo

Novo Nordisk A/S (NVO) Cash from operations

annual CFO:

$17.55B+$1.74B(+11.00%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NVO annual cash flow from operations is $17.55 billion, with the most recent change of +$1.74 billion (+11.00%) on December 31, 2024.
  • During the last 3 years, NVO annual CFO has risen by +$8.80 billion (+100.55%).
  • NVO annual CFO is now at all-time high.

Performance

NVO Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

quarterly CFO:

$3.47B+$1.93B(+125.61%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVO quarterly cash flow from operations is $3.47 billion, with the most recent change of +$1.93 billion (+125.61%) on March 31, 2025.
  • Over the past year, NVO quarterly CFO has increased by +$1.38 billion (+66.28%).
  • NVO quarterly CFO is now -52.32% below its all-time high of $7.27 billion, reached on June 30, 2024.

Performance

NVO quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

TTM CFO:

$18.93B+$1.38B(+7.87%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVO TTM cash flow from operations is $18.93 billion, with the most recent change of +$1.38 billion (+7.87%) on March 31, 2025.
  • Over the past year, NVO TTM CFO has increased by +$5.34 billion (+39.24%).
  • NVO TTM CFO is now at all-time high.

Performance

NVO TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

NVO Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+11.0%+66.3%+39.2%
3 y3 years+100.5%-2.6%+80.6%
5 y5 years+150.2%+134.6%+171.0%

NVO Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+100.5%-52.3%+166.2%at high+104.2%
5 y5-yearat high+150.2%-52.3%+876.7%at high+171.0%
alltimeall timeat high+9338.3%-52.3%+876.7%at high+8315.0%

NVO Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$3.47B(+125.6%)
$18.93B(+7.9%)
Dec 2024
$17.55B(+11.0%)
$1.54B(-76.9%)
$17.55B(+1.4%)
Sep 2024
-
$6.66B(-8.4%)
$17.32B(+4.1%)
Jun 2024
-
$7.27B(+248.7%)
$16.63B(+22.3%)
Mar 2024
-
$2.08B(+60.1%)
$13.60B(-14.0%)
Dec 2023
$15.81B(+41.4%)
$1.30B(-78.2%)
$15.81B(-1.0%)
Sep 2023
-
$5.98B(+41.1%)
$15.97B(+23.7%)
Jun 2023
-
$4.23B(-1.5%)
$12.91B(+8.3%)
Mar 2023
-
$4.30B(+193.6%)
$11.92B(+6.6%)
Dec 2022
$11.18B(+27.8%)
$1.46B(-49.7%)
$11.18B(+20.6%)
Sep 2022
-
$2.91B(-10.4%)
$9.27B(-3.8%)
Jun 2022
-
$3.25B(-8.7%)
$9.64B(-8.0%)
Mar 2022
-
$3.56B(-897.1%)
$10.49B(+19.8%)
Dec 2021
$8.75B(+9.9%)
-$446.39M(-113.6%)
$8.75B(-3.0%)
Sep 2021
-
$3.28B(-19.8%)
$9.02B(+2.4%)
Jun 2021
-
$4.09B(+124.3%)
$8.82B(+6.1%)
Mar 2021
-
$1.82B(-1147.5%)
$8.31B(+4.4%)
Dec 2020
$7.96B(+13.5%)
-$174.18M(-105.7%)
$7.96B(-11.1%)
Sep 2020
-
$3.07B(-14.3%)
$8.95B(+7.5%)
Jun 2020
-
$3.58B(+142.4%)
$8.33B(+19.1%)
Mar 2020
-
$1.48B(+81.4%)
$6.99B(-0.4%)
Dec 2019
$7.01B(-0.7%)
$815.04M(-66.7%)
$7.01B(-6.0%)
Sep 2019
-
$2.45B(+9.1%)
$7.47B(+11.1%)
Jun 2019
-
$2.25B(+49.2%)
$6.72B(-3.4%)
Mar 2019
-
$1.51B(+18.9%)
$6.95B(-1.6%)
Dec 2018
$7.07B(+12.8%)
$1.27B(-25.6%)
$7.07B(+8.5%)
Sep 2018
-
$1.70B(-31.4%)
$6.52B(-8.0%)
Jun 2018
-
$2.48B(+53.2%)
$7.08B(+15.1%)
Mar 2018
-
$1.62B(+126.9%)
$6.15B(-1.8%)
Dec 2017
$6.27B(-12.7%)
$713.69M(-68.5%)
$6.27B(-12.5%)
Sep 2017
-
$2.27B(+46.2%)
$7.16B(+0.4%)
Jun 2017
-
$1.55B(-10.5%)
$7.13B(-8.7%)
Mar 2017
-
$1.73B(+7.7%)
$7.81B(+8.7%)
Dec 2016
$7.18B(+26.1%)
$1.61B(-28.1%)
$7.18B(+1.5%)
Sep 2016
-
$2.24B(+0.3%)
$7.07B(+6.4%)
Jun 2016
-
$2.23B(+101.8%)
$6.65B(+7.6%)
Mar 2016
-
$1.11B(-26.4%)
$6.18B(+8.5%)
Dec 2015
$5.70B(+0.8%)
$1.50B(-17.2%)
$5.70B(+3.4%)
Sep 2015
-
$1.81B(+3.1%)
$5.51B(-4.9%)
Jun 2015
-
$1.76B(+182.9%)
$5.79B(+4.8%)
Mar 2015
-
$621.90M(-52.7%)
$5.53B(-2.2%)
Dec 2014
$5.65B(+22.4%)
$1.32B(-37.3%)
$5.65B(+6.6%)
Sep 2014
-
$2.10B(+40.3%)
$5.30B(+22.0%)
Jun 2014
-
$1.49B(+100.0%)
$4.35B(+5.6%)
Mar 2014
-
$746.96M(-22.5%)
$4.12B(-10.9%)
Dec 2013
$4.62B(+20.4%)
$963.64M(-15.6%)
$4.62B(+15.0%)
Sep 2013
-
$1.14B(-9.6%)
$4.02B(-3.2%)
Jun 2013
-
$1.26B(+1.0%)
$4.15B(+1.2%)
Mar 2013
-
$1.25B(+246.5%)
$4.10B(+6.9%)
DateAnnualQuarterlyTTM
Dec 2012
$3.84B(-3.9%)
$361.06M(-71.7%)
$3.84B(-8.0%)
Sep 2012
-
$1.28B(+5.0%)
$4.17B(-3.8%)
Jun 2012
-
$1.21B(+23.3%)
$4.33B(+7.2%)
Mar 2012
-
$985.15M(+42.0%)
$4.04B(+1.2%)
Dec 2011
$3.99B(+14.0%)
$693.76M(-51.8%)
$3.99B(-5.9%)
Sep 2011
-
$1.44B(+55.9%)
$4.24B(+8.2%)
Jun 2011
-
$923.02M(-1.5%)
$3.92B(+7.3%)
Mar 2011
-
$937.16M(-0.5%)
$3.65B(+4.3%)
Dec 2010
$3.50B(+21.7%)
$942.33M(-15.6%)
$3.50B(+10.4%)
Sep 2010
-
$1.12B(+69.7%)
$3.17B(+2.8%)
Jun 2010
-
$657.87M(-16.4%)
$3.09B(+5.1%)
Mar 2010
-
$786.73M(+28.5%)
$2.94B(+2.1%)
Dec 2009
$2.88B(+13.3%)
$612.27M(-40.5%)
$2.88B(+0.5%)
Sep 2009
-
$1.03B(+102.1%)
$2.86B(+13.5%)
Jun 2009
-
$509.37M(-29.9%)
$2.52B(-4.8%)
Mar 2009
-
$726.90M(+21.8%)
$2.65B(+4.3%)
Dec 2008
$2.54B(+38.2%)
$596.86M(-13.3%)
$2.54B(+5.9%)
Sep 2008
-
$688.78M(+8.0%)
$2.40B(+1.2%)
Jun 2008
-
$637.83M(+3.4%)
$2.37B(+18.1%)
Mar 2008
-
$617.11M(+35.3%)
$2.01B(+9.2%)
Dec 2007
$1.84B(+41.0%)
$456.16M(-30.9%)
$1.84B(+29.0%)
Sep 2007
-
$659.79M(+140.6%)
$1.43B(+3.6%)
Jun 2007
-
$274.19M(-38.9%)
$1.38B(-2.8%)
Mar 2007
-
$448.42M(+942.6%)
$1.41B(+8.5%)
Dec 2006
$1.30B(-10.3%)
$43.01M(-93.0%)
$1.30B(-22.2%)
Sep 2006
-
$610.21M(+94.8%)
$1.68B(+10.1%)
Jun 2006
-
$313.17M(-7.2%)
$1.52B(-2.0%)
Mar 2006
-
$337.39M(-18.7%)
$1.55B(+6.9%)
Dec 2005
$1.45B(+13.6%)
$414.94M(-9.1%)
$1.45B(+3.4%)
Sep 2005
-
$456.40M(+32.4%)
$1.41B(+3.0%)
Jun 2005
-
$344.65M(+45.4%)
$1.36B(+5.7%)
Mar 2005
-
$237.06M(-35.4%)
$1.29B(+0.9%)
Dec 2004
$1.28B(+35.9%)
$367.04M(-11.8%)
$1.28B(+40.3%)
Sep 2004
-
$416.08M(+53.8%)
$911.53M(+84.0%)
Jun 2004
-
$270.45M(+20.2%)
$495.45M(+120.2%)
Mar 2004
-
$224.99M
$224.99M
Dec 2003
$940.61M(+51.6%)
-
-
Dec 2002
$620.55M(+19.8%)
-
-
Dec 2001
$518.07M(-20.6%)
-
-
Dec 2000
$652.20M(+60.6%)
-
-
Dec 1999
$406.08M(+11.1%)
-
-
Dec 1998
$365.54M(-20.5%)
-
-
Dec 1997
$459.82M(+38.7%)
-
-
Dec 1996
$331.58M(-26.6%)
-
-
Dec 1995
$451.90M(+7.7%)
-
-
Dec 1994
$419.67M(+42.1%)
-
-
Dec 1993
$295.30M(+33.9%)
-
-
Dec 1992
$220.47M(+18.6%)
-
-
Dec 1991
$185.96M(-23.7%)
-
-
Dec 1990
$243.65M
-
-

FAQ

  • What is Novo Nordisk A/S annual cash flow from operations?
  • What is the all time high annual CFO for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual CFO year-on-year change?
  • What is Novo Nordisk A/S quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly CFO year-on-year change?
  • What is Novo Nordisk A/S TTM cash flow from operations?
  • What is the all time high TTM CFO for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM CFO year-on-year change?

What is Novo Nordisk A/S annual cash flow from operations?

The current annual CFO of NVO is $17.55B

What is the all time high annual CFO for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual cash flow from operations is $17.55B

What is Novo Nordisk A/S annual CFO year-on-year change?

Over the past year, NVO annual cash flow from operations has changed by +$1.74B (+11.00%)

What is Novo Nordisk A/S quarterly cash flow from operations?

The current quarterly CFO of NVO is $3.47B

What is the all time high quarterly CFO for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly cash flow from operations is $7.27B

What is Novo Nordisk A/S quarterly CFO year-on-year change?

Over the past year, NVO quarterly cash flow from operations has changed by +$1.38B (+66.28%)

What is Novo Nordisk A/S TTM cash flow from operations?

The current TTM CFO of NVO is $18.93B

What is the all time high TTM CFO for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM cash flow from operations is $18.93B

What is Novo Nordisk A/S TTM CFO year-on-year change?

Over the past year, NVO TTM cash flow from operations has changed by +$5.34B (+39.24%)
On this page